Get the Stockscreener App
1.67
1.76%
-0.03
After Hours:
1.67
Q 32 Bio Inc stock is traded at $1.67, with a volume of 154.64K.
It is down -1.76% in the last 24 hours and down -4.02% over the past month.
Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body's first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function. ADX-097, the lead product candidate from Q32's complement inhibitor platform, is a humanized anti-C3d monoclonal antibody fusion protein.
See More
Previous Close:
$1.70
Open:
$1.68
24h Volume:
154.64K
Relative Volume:
0.99
Market Cap:
$23.18M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-12.11%
1M Performance:
-4.02%
6M Performance:
-54.86%
1Y Performance:
-91.51%
1-Day Range:
$1.63
$1.85
1-Week Range:
$1.63
$1.98
52-Week Range:
$1.38
$53.79
Q 32 Bio Inc Stock (QTTB) Company Profile
Name
Q 32 Bio Inc
Sector
Industry
Phone
781-999-0232
Address
830 WINTER STREET, WALTHAM
Compare QTTB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
QTTB
Q 32 Bio Inc
|
1.67 | 23.18M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.45 | 115.69B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
529.24 | 53.25B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
307.99 | 39.22B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
577.89 | 35.78B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
269.63 | 27.68B | 3.81B | -644.79M | -669.77M | -6.24 |
Q 32 Bio Inc Stock (QTTB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-11-25 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Feb-11-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-11-24 | Downgrade | Guggenheim | Buy → Neutral |
| Dec-11-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Dec-11-24 | Downgrade | Raymond James | Strong Buy → Outperform |
| Dec-11-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-06-24 | Initiated | BMO Capital Markets | Outperform |
| Oct-24-24 | Initiated | Raymond James | Strong Buy |
| Sep-11-24 | Initiated | Wells Fargo | Overweight |
| Jun-17-24 | Initiated | Guggenheim | Buy |
| May-21-24 | Initiated | Leerink Partners | Outperform |
| Apr-11-24 | Initiated | Oppenheimer | Outperform |
| Apr-02-24 | Initiated | Piper Sandler | Overweight |
| Jul-28-23 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Feb-22-22 | Reiterated | BTIG Research | Neutral |
| Feb-22-22 | Downgrade | Oppenheimer | Outperform → Perform |
| Feb-22-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Mar-02-21 | Initiated | Stifel | Hold |
| Dec-14-20 | Resumed | H.C. Wainwright | Buy |
| Aug-11-20 | Reiterated | H.C. Wainwright | Buy |
| Jun-25-20 | Resumed | BofA/Merrill | Buy |
| May-13-20 | Initiated | RBC Capital Mkts | Outperform |
| Mar-16-20 | Upgrade | Oppenheimer | Perform → Outperform |
| Feb-24-20 | Initiated | Chardan Capital Markets | Buy |
| Nov-01-19 | Initiated | Oppenheimer | Perform |
| Sep-10-19 | Initiated | Robert W. Baird | Outperform |
| Apr-12-19 | Initiated | Evercore ISI | Outperform |
View All
Q 32 Bio Inc Stock (QTTB) Latest News
Millennium Management LLC Sells 89,618 Shares of Q32 Bio Inc. (NASDAQ:QTTB) - Defense World
Two Sigma Investments LP Trims Holdings in Organigram Holdings Inc. (NASDAQ:OGI) - Defense World
57,600 Shares in Hyliion Holdings Corp. (NYSE:HYLN) Purchased by Two Sigma Investments LP - Defense World
Two Sigma Investments LP Takes Position in MYT Netherlands Parent B.V. (NYSE:MYTE) - Defense World
Two Sigma Investments LP Sells 430,709 Shares of bluebird bio, Inc. (NASDAQ:BLUE) - Defense World
Millennium Management LLC Sells 300,456 Shares of Trilogy Metals Inc. (NYSEAMERICAN:TMQ) - Defense World
Millennium Management LLC Has $148,000 Stake in Actinium Pharmaceuticals, Inc. (NYSE:ATNM) - Defense World
Millennium Management LLC Sells 266,668 Shares of Accuray Incorporated (NASDAQ:ARAY) - Defense World
Two Sigma Investments LP Takes $206,000 Position in Avino Silver & Gold Mines Ltd. (NYSE:ASM) - Defense World
Two Sigma Investments LP Takes $154,000 Position in Nomura Holdings, Inc. (NYSE:NMR) - Defense World
Stingray Group (TSE:RAY.A) Given New C$13.50 Price Target at CIBC - Defense World
Millennium Management LLC Cuts Holdings in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - Defense World
Finance Watch: Insmed Cashes In On Positive Data With $750m Offering - insights.citeline.com
Fierce Biotech Layoff Tracker 2025: ADC Tx lets go of 30% of workers; Vertex sheds 125 staffers - Fierce Biotech
19,009 Shares in Q32 Bio Inc. (NASDAQ:QTTB) Acquired by Squarepoint Ops LLC - Defense World
Squarepoint Ops LLC Grows Position in ProQR Therapeutics (NASDAQ:PRQR) - Defense World
Ivanhoe Electric Inc. (NYSEAMERICAN:IE) Shares Sold by Bank of America Corp DE - Defense World
Public Employees Retirement System of Ohio Buys Shares of 7,540 Q32 Bio Inc. (NASDAQ:QTTB) - Defense World
Radware Ltd. (NASDAQ:RDWR) Shares Purchased by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Raises Stake in BioLife Solutions, Inc. (NASDAQ:BLFS) - Defense World
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Raises Stock Position in Ecovyst Inc. (NYSE:ECVT) - Defense World
Ameriprise Financial Inc. Takes Position in Q32 Bio Inc. (NASDAQ:QTTB) - Defense World
Rheinmetall (OTCMKTS:RNMBY) Raised to Strong-Buy at BNP Paribas - Defense World
Neuberger Berman Municipal Fund Inc. (NYSEAMERICAN:NBH) Shares Purchased by Nuveen Asset Management LLC - Defense World
Two Sigma Investments LP Raises Stock Position in Steelcase Inc. (NYSE:SCS) - Defense World
Public Employees Retirement System of Ohio Invests $137,000 in Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World
Layoff Tracker: Capsida Downsizes as Part of Shift to Clinical-Stage Company - BioSpace
Pangaea Logistics Solutions, Ltd. (NASDAQ:PANL) Shares Sold by BNP Paribas Financial Markets - Defense World
Q32 Bio Inc. (NASDAQ:QTTB) Shares Bought by Deutsche Bank AG - Defense World
QTTBQ32 Bio Reports Fourth Quarter 2024 Financial Results and Provides Corporate Update - Revista ADVFN
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Sells 1,153 Shares of ASE Technology Holding Co., Ltd. (NYSE:ASX) - Defense World
Q32 Bio receives Nasdaq noncompliance notice - Investing.com
Q32 Bio receives Nasdaq noncompliance notice By Investing.com - Investing.com UK
HC Wainwright Has Positive Forecast for CASI Q2 Earnings - Defense World
Q32 Bio Inc. (NASDAQ:QTTB) Receives $24.71 Consensus Price Target from Analysts - Defense World
Cubist Systematic Strategies LLC Invests $48,000 in ThredUp Inc. (NASDAQ:TDUP) - Defense World
494,356 Shares in Amazon.com, Inc. (NASDAQ:AMZN) Bought by Candlestick Capital Management LP - Defense World
Capstone Financial Advisors Inc. Lowers Holdings in Amazon.com, Inc. (NASDAQ:AMZN) - Defense World
Cubist Systematic Strategies LLC Makes New $93,000 Investment in TrustCo Bank Corp NY (NASDAQ:TRST) - Defense World
Amazon.com, Inc. (NASDAQ:AMZN) Shares Sold by 11 Capital Partners LP - Defense World
Utah Retirement Systems Purchases 19,500 Shares of Amazon.com, Inc. (NASDAQ:AMZN) - Defense World
10,895 Shares in Foghorn Therapeutics Inc. (NASDAQ:FHTX) Acquired by Cubist Systematic Strategies LLC - Defense World
Cubist Systematic Strategies LLC Acquires New Shares in Blink Charging Co. (NASDAQ:BLNK) - Defense World
10,746 Shares in Q32 Bio Inc. (NASDAQ:QTTB) Bought by Raymond James Financial Inc. - Defense World
Q32 Bio Stock Turns Retail Trader Heads After FDA Grants Fast Track For Alopecia Drug - MSN
Q32 Bio: Q1 Earnings Snapshot - New Haven Register
Q32 Bio Inc. Reports Q1 2025 Financial Results - TipRanks
Q32 Bio Reports First Quarter 2025 Financial Results and Provides Corporate Update - Kilgore News Herald
Q32 Bio Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com
Q32 Bio Inc expected to post a loss of $1.23 a shareEarnings Preview - TradingView
Q 32 Bio Inc Stock (QTTB) Financials Data
There is no financial data for Q 32 Bio Inc (QTTB). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
1.91%
1.17%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):